Inflammatory Responses Completed Phase 2 Trials for Paricalcitol (DB00910)

Also known as: Inflammatory Response

IndicationStatusPhase
DBCOND0062877 (Inflammatory Responses)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00686751Immune Effects of Vitamin D in Hemodialysis PatientsPrevention